We are live on ! Find out more
RVM

RiverVest Venture Management Portfolio holdings

AUM $6.84M
1-Year Est. Return 7.71%
This Fund
S&P 500
This Quarter Est. Return
-16.75%
1 Year Est. Return
-7.71%
3 Year Est. Return
-16.51%
5 Year Est. Return
10 Year Est. Return
AUM
$649M
AUM Growth
-$261M
Cap. Flow
-$112M
Cap. Flow %
-17.28%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ALLK
Allakos
ALLK
+$109M
2
OTIC
Otonomy, Inc.
OTIC
+$3.25M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALLK
1
DELISTED
Allakos
ALLK
$561M 86.41%
4,887,932
-862,574
-15% -$109M
MIRM icon
2
Mirum Pharmaceuticals
MIRM
$6.08B
$38.1M 5.86%
1,921,118
SPRB
3
Spruce Biosciences
SPRB
$182M
$35.7M 5.49%
28,644
VAPO
4
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$14.5M 2.24%
75,622
OTIC
5
DELISTED
Otonomy, Inc.
OTIC
-501,899
Closed -$3.25M

Similar funds

RiverVest Venture Management's Q1 2021 Portfolio in Review

As of Q1 2021, RiverVest Venture Management held 5 positions worth $649M, down 29% from $910M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

RiverVest Venture Management withdrew a net $112M in Q1 2021, closing 1 position and reducing 1 holding. Its most notable exit was Otonomy, Inc., an estimated $3.25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • RiverVest Venture Management's biggest Q1 2021 reduction was Allakos, cutting an estimated $109M.
  • RiverVest Venture Management fully exited Otonomy, Inc. in Q1 2021, selling an estimated $3.25M.
  • RiverVest Venture Management's ten largest holdings make up 100% of its $649M portfolio in Q1 2021.
  • RiverVest Venture Management opened 0 new positions and closed 1 in Q1 2021.
  • RiverVest Venture Management's portfolio value fell 29% quarter-over-quarter to $649M.

Based on RiverVest Venture Management's 13F filing for Q1 2021, filed 11 Aug 2021.